Xin‐Da Zhou

3.1k total citations
61 papers, 2.5k citations indexed

About

Xin‐Da Zhou is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Xin‐Da Zhou has authored 61 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Xin‐Da Zhou's work include Hepatocellular Carcinoma Treatment and Prognosis (41 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Cancer, Lipids, and Metabolism (10 papers). Xin‐Da Zhou is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (41 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Cancer, Lipids, and Metabolism (10 papers). Xin‐Da Zhou collaborates with scholars based in China, India and United States. Xin‐Da Zhou's co-authors include Zhao–You Tang, Zeng‐Chen Ma, Zhao–You Tang, Zhi-Quan Wu, Jia Fan, Lun–Xiu Qin, Zhiying Lin, Ye‐Qin Yu, Bing‐Hui Yang and Sheng‐Long Ye and has published in prestigious journals such as Cancer, World Journal of Gastroenterology and World Journal of Surgery.

In The Last Decade

Xin‐Da Zhou

61 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin‐Da Zhou China 27 1.5k 678 672 610 541 61 2.5k
Zeng‐Chen Ma China 22 1.3k 0.9× 457 0.7× 539 0.8× 523 0.9× 437 0.8× 44 2.0k
Gar-Yang Chau Taiwan 20 2.0k 1.4× 589 0.9× 1.1k 1.7× 491 0.8× 634 1.2× 37 2.9k
Hideki Yokoo Japan 26 945 0.6× 507 0.7× 511 0.8× 658 1.1× 512 0.9× 114 2.0k
Binkui Li China 30 932 0.6× 1.3k 1.9× 519 0.8× 503 0.8× 743 1.4× 103 2.8k
J.F. Geschwind United States 22 834 0.6× 765 1.1× 428 0.6× 314 0.5× 327 0.6× 44 2.3k
Zhengfeng Yin China 21 535 0.4× 522 0.8× 301 0.4× 361 0.6× 732 1.4× 40 1.6k
Makoto Chuma Japan 21 806 0.6× 643 0.9× 669 1.0× 197 0.3× 323 0.6× 70 1.9k
Till Krech Germany 28 493 0.3× 795 1.2× 461 0.7× 251 0.4× 456 0.8× 79 1.9k
Stefania Brozzetti Italy 21 337 0.2× 586 0.9× 343 0.5× 424 0.7× 468 0.9× 50 1.6k
Camilla Pilati France 19 542 0.4× 1.1k 1.6× 373 0.6× 408 0.7× 1.1k 2.0× 32 2.7k

Countries citing papers authored by Xin‐Da Zhou

Since Specialization
Citations

This map shows the geographic impact of Xin‐Da Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin‐Da Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin‐Da Zhou more than expected).

Fields of papers citing papers by Xin‐Da Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin‐Da Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin‐Da Zhou. The network helps show where Xin‐Da Zhou may publish in the future.

Co-authorship network of co-authors of Xin‐Da Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xin‐Da Zhou. A scholar is included among the top collaborators of Xin‐Da Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin‐Da Zhou. Xin‐Da Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Jia, Zhi-Quan Wu, Xin‐Da Zhou, et al.. (2009). Surgical treatment of primary hepatocellular carcinoma: a 20-year clinical experience in 7566 patients.. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 8(2). 99–102. 1 indexed citations
2.
Zhou, Xin‐Da, Zhao–You Tang, Jia Fan, et al.. (2009). Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 135(8). 1073–1080. 72 indexed citations
3.
Sun, Hui‐Chuan, Zhao–You Tang, Lu Wang, et al.. (2006). Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. Journal of Cancer Research and Clinical Oncology. 132(7). 458–465. 177 indexed citations
4.
Sun, Hui‐Chuan, Zhao–You Tang, Zeng‐Chen Ma, et al.. (2005). The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background. Journal of Cancer Research and Clinical Oncology. 131(5). 284–288. 19 indexed citations
5.
Tang, Zhao–You, Sheng‐Long Ye, Yinkun Liu, et al.. (2004). A decade?s studies on metastasis of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 130(4). 187–196. 386 indexed citations
6.
Tang, Zhao–You, Xin‐Da Zhou, Zeng‐Chen Ma, et al.. (2004). Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.. PubMed. 3(4). 495–8. 23 indexed citations
7.
Zhou, Xin‐Da, Zhao–You Tang, Zeng‐Chen Ma, et al.. (2003). Surgery for large primary liver cancer more than 10�cm in diameter. Journal of Cancer Research and Clinical Oncology. 129(9). 543–548. 35 indexed citations
8.
Zhou, Xin‐Da, Zhao–You Tang, Bing‐Hui Yang, et al.. (2001). Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 91(8). 1479–1486. 229 indexed citations
9.
Fan, Jia, Zhao–You Tang, Zhi-Quan Wu, et al.. (1998). Improved Survival with Resectionafter Transcatheter ArterialChemoembolization (TACE) for Unresectable Hepatocellular Carcinoma. Digestive Surgery. 15(6). 674–678. 72 indexed citations
10.
Zhou, Xin‐Da & Zhao–You Tang. (1998). Cryotherapy for primary liver cancer. Seminars in Surgical Oncology. 14(2). 171–174. 77 indexed citations
11.
Cheng, Shuqun, et al.. (1997). Ultrastructural observation of liver tissue ablation induced by high-intensity focused ultrasound. World Journal of Gastroenterology. 3(3). 134–136. 3 indexed citations
12.
Tang, Zhao–You, et al.. (1996). mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential. Journal of Cancer Research and Clinical Oncology. 122(1). 55–58. 4 indexed citations
13.
Zhou, Xin‐Da, Zhao–You Tang, Ye‐Qin Yu, et al.. (1995). Characteristics and prognosis of primary liver cancer in young patients in China. Journal of Gastroenterology. 30(5). 632–635. 6 indexed citations
14.
Zhou, Xin‐Da, Zeng‐Chen Ma, Kang–Da Liu, et al.. (1994). The role of targeting therapy in cytoreduction and sequential resection of unresectable hepatocellular carcinoma. Chinese Journal of Cancer Research. 6(1). 24–30. 1 indexed citations
15.
Zhou, Xin‐Da, et al.. (1993). Experience with resection of segment VIII of liver for hepatocellular carcinoma. Seminars in Surgical Oncology. 9(4). 305–308. 2 indexed citations
16.
Tang, Zhao–You, Ye‐Qin Yu, & Xin‐Da Zhou. (1993). Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s. Seminars in Surgical Oncology. 9(4). 293–297. 27 indexed citations
17.
Zhou, Xin‐Da, et al.. (1993). Microwave surgery in the treatment of hepatocellular carcinoma. Seminars in Surgical Oncology. 9(4). 318–322. 26 indexed citations
18.
Yu, Ye‐Qin, Dongbo Xu, Xin‐Da Zhou, et al.. (1993). Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer. 71(1). 62–65. 97 indexed citations
19.
Zhou, Xin‐Da, Zhao–You Tang, Ye‐Qin Yu, et al.. (1991). Solitary minute hepatocellular carcinoma. A study of 14 patients. Cancer. 67(11). 2855–2858. 14 indexed citations
20.
Tang, Zhao–You, Ye‐Qin Yu, Zeng‐Chen Ma, et al.. (1989). Conversion of surgically verified unresectable to resectable hepatocellular carcinoma. Chinese Journal of Cancer Research. 1(3). 41–47. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zeng‐Chen Ma Breakdown of academic impact, for papers by Gar-Yang Chau Breakdown of academic impact, for papers by Hideki Yokoo Breakdown of academic impact, for papers by Binkui Li Breakdown of academic impact, for papers by J.F. Geschwind Breakdown of academic impact, for papers by Zhengfeng Yin Breakdown of academic impact, for papers by Makoto Chuma Breakdown of academic impact, for papers by Till Krech Breakdown of academic impact, for papers by Stefania Brozzetti Breakdown of academic impact, for papers by Camilla Pilati
Rankless by CCL
2026